RU2008139377A - SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES - Google Patents
SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES Download PDFInfo
- Publication number
- RU2008139377A RU2008139377A RU2008139377/15A RU2008139377A RU2008139377A RU 2008139377 A RU2008139377 A RU 2008139377A RU 2008139377/15 A RU2008139377/15 A RU 2008139377/15A RU 2008139377 A RU2008139377 A RU 2008139377A RU 2008139377 A RU2008139377 A RU 2008139377A
- Authority
- RU
- Russia
- Prior art keywords
- stearic acid
- solid dosage
- dosage form
- polyvinylpyrrolidone
- salt
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Твердая дозированная лекарственная форма для лечения сахарного диабета, содержащая в качестве действующего вещества комбинацию терапевтически эффективных количеств метформина, рибоксин, бутадиона, аргинина, гидроксихлорохина и гликлазида в соотношении 5-40:4-30:3-20:3-20:2-10:1 и целевые добавки, в качестве которых она содержит сорбитол, поливинилпирролидон, стеариновую кислоту и/или соль стеариновой кислоты и кроскармеллозу натрия при следующем соотношении компонентов, мас.%: ! метформин 20,0-40,0 рибоксин 17,0-35,0 бутадион 7,0-20,0 аргинин 7,0-20,0 гидроксихлорохин 5,0-15,0 гликлазид 1,0-3,0 сорбитол 2,0-8,0 поливинилпирролидон 1,5-4,5 стеариновая кислота и/или соль стеариновой кислоты 0,2-1,0 кроскармеллоза натрия 0,5-2,0 ! 2. Твердая дозированная лекарственная форма по п.1, отличающаяся тем, что в качестве поливинилпирролидона она содержит, преимущественно, коллидон 25 (повидон). ! 3. Твердая дозированная лекарственная форма по п.1 или 2, отличающаяся тем, что в качестве соли стеариновой кислоты она содержит магниевую и/или кальциевую соли. ! 4. Твердая дозированная лекарственная форма по п.1, отличающаяся тем, что она выполнена в виде твердой лекарственной формы, преимущественно, в виде таблетки. ! 5. Твердая дозированная лекарственная форма по п.1, отличающаяся тем, что она выполнена в виде порошка, не содержащего сорбитол, поливинилпирролидон, стеариновую кислоту и/или соль стеариновой кислоты, кроскармеллозы натрия. 1. A solid dosage form for the treatment of diabetes mellitus containing, as an active ingredient, a combination of therapeutically effective amounts of metformin, riboxin, butadione, arginine, hydroxychloroquine and glyclazide in a ratio of 5-40: 4-30: 3-20: 3-20: 2 -10: 1 and target additives, in which it contains sorbitol, polyvinylpyrrolidone, stearic acid and / or a salt of stearic acid and croscarmellose sodium in the following ratio, wt.%:! metformin 20.0-40.0 riboxin 17.0-35.0 butadione 7.0-20.0 arginine 7.0-20.0 hydroxychloroquine 5.0-15.0 gliclazide 1.0-3.0 sorbitol 2 , 0-8.0 polyvinylpyrrolidone 1.5-4.5 stearic acid and / or stearic acid salt 0.2-1.0 croscarmellose sodium 0.5-2.0! 2. The solid dosage form according to claim 1, characterized in that as polyvinylpyrrolidone it contains mainly collidone 25 (povidone). ! 3. The solid dosage form according to claim 1 or 2, characterized in that as the salt of stearic acid, it contains magnesium and / or calcium salts. ! 4. The solid dosage form according to claim 1, characterized in that it is made in the form of a solid dosage form, mainly in the form of a tablet. ! 5. The solid dosage form according to claim 1, characterized in that it is made in the form of a powder that does not contain sorbitol, polyvinylpyrrolidone, stearic acid and / or a salt of stearic acid, croscarmellose sodium.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008139377/15A RU2008139377A (en) | 2008-10-06 | 2008-10-06 | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008139377/15A RU2008139377A (en) | 2008-10-06 | 2008-10-06 | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2008139377A true RU2008139377A (en) | 2010-04-20 |
Family
ID=46274788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008139377/15A RU2008139377A (en) | 2008-10-06 | 2008-10-06 | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2008139377A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2481124C1 (en) * | 2011-10-27 | 2013-05-10 | Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ" | Pharmaceutical combination of atorvastatin and nicergolin for preventing or treating cerebrovascular disease |
-
2008
- 2008-10-06 RU RU2008139377/15A patent/RU2008139377A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2481124C1 (en) * | 2011-10-27 | 2013-05-10 | Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ" | Pharmaceutical combination of atorvastatin and nicergolin for preventing or treating cerebrovascular disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011153403A (en) | STABILIZED COMPOSITION CONTAINING AT LEAST ONE ADRENERGIC COMPOUND | |
RU2008113588A (en) | 2-Ethyl-6-methyl-3-hydroxypyridinium hydroxybutanedioate possessing anti-ischemic, cerebroprotective, neurotropic and lipid-regulating activity, pharmaceuticals | |
RU2015151938A (en) | TABLETABLE MEDICINE (4'-TRIFFORMETHYLPHENYL) AMID (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID WITH IMPROVED STABILITY | |
RU2007119641A (en) | COMPOSITION INCLUDING ACETAMINOPHEN, CAFFEINE AND OPTIONAL ASPIRINE IN A MIXTURE WITH AN ALKALINE AGENT FOR INCREASING ABSORPTION | |
RU2013136384A (en) | COMPOSITION CONTAINING SODIUM-Glucose Inhibitors 1 and 2 Inhibitors, and Methods for Their Use | |
RU2008139377A (en) | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES | |
RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
RU2013126056A (en) | COMPOSITION FOR TREATMENT OF INVERVATION DISORDERS (OPTIONS) | |
RU2015114709A (en) | STABLE INJECTION COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | |
RU2010101936A (en) | ANTIOXIDANT COMPOSITION | |
RU2006116540A (en) | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES | |
RU2006142336A (en) | PHARMACEUTICAL COMPOSITION BASED ON LADASTEN | |
RU2004118448A (en) | PHARMACEUTICAL COMPOSITION WITH PROLONGED GLYCLAZIDE RELEASE | |
RU2009101126A (en) | PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | |
RU2005110207A (en) | MUKOLITIC PHARMACEUTICAL COMPOSITION | |
RU2009142700A (en) | ANTI-INFLAMMATORY AND ANTI-ALLERGIC MEDICINE AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | |
RU2009114885A (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLID ORAL DRUG FORM FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT | |
RU2008113043A (en) | PHARMACEUTICAL COMPOSITION WITH ANTI-MIRACLE ACTION | |
RU2016146653A (en) | PHARMACEUTICAL COMPOSITION BASED ON CHLORBENZOYLAMINOADAMANTHANE, INCREASING PHYSICAL PERFORMANCE IN THE CONDITIONS OF HIGH AND LOW TEMPERATURES | |
RU2009134473A (en) | COMBINED TUBERCULOSIS DRUG | |
RU2007112544A (en) | PHARMACEUTICAL COMPOSITION HAVING ANTI-VESSEL AND PSYCHOTROPIC ACTION | |
RU2010134123A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES | |
RU2013157797A (en) | PHARMACEUTICAL COMPOSITION FOR TREATING SUGAR DIABETES | |
RU2008152455A (en) | HEAT ACCUMULATING COMPOSITION | |
RU2008145723A (en) | DRUG ACTIVITY MEDICINAL PRODUCT |